Below appears the 2013 Report from PhRMA on the industries pipeline of new biologic drugs. This overview outlines drugs by therapeutic category, by clinical phase and by company. There are 907 biologics in development covering more than 100 diseases.
The major category level includes: 338 drugs for cancers, 176 aimed at various infectious diseases, 71 at automimmune diseases, and 58 at cardiovascular disease. Other disease categories inclue diabetes, digestive disorders, genetics diseases, neurologic and respiratory diseases.
Posted by Bruce Lehr Mar 25th 2013.